Zeta Cytokeratin-20 (CK20) Antibody. Zeta’s rabbit recombinant monoclonal antibody recognizes an intermediate filament protein of 46kDa, identified as Cytokeratin-20 (CK20). Cytokeratin-20 (CK20) is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. Cytokeratin-20 (CK20) is a useful marker of pancreatic and colorectal cancer. Cytokeratin-20 (CK20) is expressed under normal, hyperplastic and neoplastic conditions. Cytokeratin-20 has been detected in adenocarcinomas of the colon, stomach and biliary tract whereas breast carcinomas are generally non-reactive.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.